The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy
Author(s) -
Yinxiang Ren,
Xiaobin Li,
Wei Liu,
Xuguang Yang,
Xin Liu,
Yu Luo
Publication year - 2022
Publication title -
journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.228
H-Index - 54
eISSN - 1687-8469
pISSN - 1687-8450
DOI - 10.1155/2022/7319641
Subject(s) - sorafenib , cancer research , rac1 , viability assay , apoptosis , hepatocellular carcinoma , cell cycle , mtt assay , combination therapy , cell growth , downregulation and upregulation , glycolysis , in vivo , cell , cell cycle checkpoint , medicine , pharmacology , biology , signal transduction , cancer , microbiology and biotechnology , metabolism , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom